lutein has been researched along with Disease Models, Animal in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (22.92) | 29.6817 |
| 2010's | 30 (62.50) | 24.3611 |
| 2020's | 7 (14.58) | 2.80 |
| Authors | Studies |
|---|---|
| Addo, EK; Arunkumar, R; Bernstein, PS; Hartnett, ME; Li, B | 1 |
| Akturan, S; Cimen, FK; Kurt, N; Malkoc, İ; Mammadov, R; Suleyman, B; Suleyman, Z | 1 |
| Arslan, FD; Camlar, M; Diniz, G; Oren, MM; Ozer, F; Turk, C | 1 |
| Ahmadi, A; Bandariyan, E; Mogheiseh, A | 1 |
| Altuner, D; Bayram, R; Coban, TA; Dilber, M; Erhan, E; Salcan, I; Suleyman, B; Suleyman, H; Yazici, GN | 1 |
| Araujo, SM; Barrientos, MS; Bortolotto, VC; De Carvalho, AS; Fernandes, EJ; Gonçalves, OH; Guerra, GP; Leimann, FV; Poetini, MR; Prigol, M; Ramborger, BP; Roehrs, R; Santos Musachio, EA | 1 |
| Al-Rafiah, AR; Mehdar, KM | 1 |
| Abd-Elmawla, MA; Abdelmonem, M; Amin, HAA; Essam, RM; Ibrahim, SM | 1 |
| Juturu, V; Muz, OE; Orhan, C; Sahin, K; Sahin, N; Tuzcu, M | 1 |
| Chen, S; Connor, KM; Kimura, K; Nanri, T; Uchi, SH; Yanai, R | 1 |
| Beight, C; Yan, W; Yu, M | 2 |
| Fang, J; Gao, K; Huang, C; Li, H; Zhu, J | 1 |
| Bartz-Schmidt, KU; Hofmann, J; Januschowski, K; Krupp, C; Mueller, S; Schnichels, S; Spitzer, M; Szurman, P | 1 |
| Boeing, T; da Silva, LM; da Silva, RCMVAF; de Andrade, SF; de Souza, P; Dos Santos, AC; Klein-Júnior, LC; Longo, B; Mariano, LNB; Mariott, M; Mees, M; Meurer, MC; Santos França, TC; Somensi, LB | 1 |
| Inaba, T; Kawakita, T; Kawashima, M; Nakamura, S; Ozawa, Y; Shinmura, K; Tsubota, K; Watanabe, M | 1 |
| Kuttan, R; Sindhu, ER | 2 |
| Wang, M; Wang, S; Zhang, S; Zhao, L | 1 |
| Liu, WL; Liu, ZG; Qi, ZC; Wang, WZ | 1 |
| Fernández-García, V; Fernández-Robredo, P; García-García, L; García-Layana, A; Heras-Mulero, H; Ivanescu, AA; Moreno-Orduna, M; Recalde, S; Redondo-Exposito, A; Sádaba-Echarri, LM | 1 |
| Gao, DH; Hao, LP; Liu, LG; Qiu, X; Sun, XF; Xiang, X; Xiong, YF; Zhu, TS | 1 |
| Cheng, F; Lin, CS; Wan, JF; Yan, FF; Zhang, Q | 1 |
| McGill, TJ; Neuringer, M; Renner, LM | 1 |
| Amengual, J; Golczak, M; Palczewski, G; von Lintig, J; Widjaja-Adhi, MA | 1 |
| Cheng, YP; Ke, CY; Kuo, CC; Lee, YJ | 1 |
| Aguilar, D; Blesso, CN; DiMarco, DM; Fernandez, ML; Gannon, S; Hu, S; Luo, Y; Missimer, A; Murillo, AG; Norris, GH; Smyth, JA | 1 |
| Burnim, SB; Fu, Z; Lo, AC; Meng, SS; Smith, LE | 1 |
| Au Eong, KG; Goenadi, CJ; Lun, K; Neelam, K; Yip, CC | 1 |
| Karlina, MV; Kosman, VM; Makarov, VG; Pozharitskaia, ON; Shikov, AN | 1 |
| Almansa, I; Arnal, E; Barcia, JM; Bosch-Morell, F; Diaz-Llopis, M; Miranda, M; Muriach, M; Romero, FJ | 1 |
| Fu, ZJ; Jang, WC; Li, SY; Lo, AC; Ma, H; So, KF; Wong, D | 1 |
| Imamura, Y; Ishida, S; Kobayashi, S; Kurihara, T; Noda, K; Ozawa, Y; Sasaki, M; Tsubota, K | 1 |
| Arnal, E; Barcia, J; Bosch-Morell, F; Miranda, M; Romero, FJ | 1 |
| Firdous, AP; Kuttan, R; Preethi, KC; Sindhu, ER | 1 |
| Baskaran, V; Sangeetha, RK | 1 |
| Barker, FM; Gerss, J; Johnson, EJ; Koepcke, W; Neuringer, M; Schalch, W; Snodderly, DM | 1 |
| Fu, ZJ; Li, SY; Lo, AC; Wong, D; Woo, T; Yang, D | 1 |
| Kamoshita, M; Miyake, S; Ozawa, Y; Sasaki, M; Takahashi, N; Tsubota, K | 1 |
| Chan, HH; Fu, ZJ; Fung, FK; Li, SY; Lo, AC; Wong, D | 1 |
| Lai, WW; Li, SY; Lo, AC; Wong, D; Woo, TT | 1 |
| Bonnefoy, M; Drai, J; Kostka, T | 1 |
| Dilsiz, N; Reichenbach, A; Sahaboglu, A; Yildiz, MZ | 1 |
| Hirano, T; Ilieva, I; Iseki, K; Jin, XH; Koyama, Y; Ohgami, K; Ohno, S; Shiratori, K; Suzuki, Y; Yoshida, K | 1 |
| Fernández-Robredo, P; García-Layana, A; Recalde, S; Rodríguez, JA; Sádaba, LM | 1 |
| Ishida, S; Izumi-Nagai, K; Nagai, N; Ohgami, K; Ohno, S; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K; Umezawa, K | 1 |
| Khachik, F; Masuda, M; Murakoshi, M; Narisawa, T; Nishino, H; Okuda, M; Onozuka, M; Satomi, Y; Takasuka, N; Takayasu, J; Tokuda, H; Tsuruta, J; Yamaguchi, S; Yano, M | 1 |
| Drake, T; Dwyer, JH; Dwyer, KM; Fogelman, AM; Hama-Levy, S; Hassan, K; Hough, G; Merz, CN; Navab, M; Shircore, A; Sun, P; Wang, X | 1 |
3 review(s) available for lutein and Disease Models, Animal
| Article | Year |
|---|---|
Putative protective role of lutein and zeaxanthin in diabetic retinopathy.
Topics: Animals; Antioxidants; Diabetic Retinopathy; Dietary Supplements; Disease Models, Animal; Humans; Lutein; Macular Degeneration; Neuroprotective Agents; Reactive Oxygen Species; Zeaxanthins | 2017 |
Neuroprotective effects of lutein in the retina.
Topics: Animals; Antioxidants; Disease Models, Animal; Humans; Lutein; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Retina; Retinal Diseases | 2012 |
[Antioxidants to slow aging, facts and perspectives].
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotenoids; Cataract; Chronic Disease; Disease Models, Animal; Evidence-Based Medicine; Free Radicals; Humans; Lutein; Macular Degeneration; Neoplasms; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Vitamin E | 2002 |
45 other study(ies) available for lutein and Disease Models, Animal
| Article | Year |
|---|---|
Prenatal Carotenoid Supplementation With Lutein or Zeaxanthin Ameliorates Oxygen-Induced Retinopathy (OIR) in Bco2-/- Macular Pigment Mice.
Topics: Animals; Dietary Supplements; Dioxygenases; Disease Models, Animal; Female; Humans; Infant; Infant, Newborn; Lutein; Macular Pigment; Mice; Oxygen; Placenta; Pregnancy; Retinopathy of Prematurity; Zeaxanthins | 2023 |
Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment.
Topics: Animals; Antioxidants; Disease Models, Animal; Glutathione; Interleukin-1beta; Lung; Lung Diseases; Lutein; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Rats, Wistar; Tumor Necrosis Factor-alpha | 2019 |
Effects of Lutein on Brain Damage and Vasospasm in an Experimental Subarachnoid Hemorrhage Model.
Topics: Animals; Brain Injuries; Disease Models, Animal; Female; Lutein; Male; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2020 |
The effect of lutein and Urtica dioica extract on in vitro production of embryo and oxidative status in polycystic ovary syndrome in a model of mice.
Topics: Animals; Disease Models, Animal; Embryo, Mammalian; Estradiol; Female; Lutein; Mice; Oocytes; Ovary; Oxidative Stress; Plant Extracts; Polycystic Ovary Syndrome; Urtica dioica | 2021 |
Protective effect of lutein against acrolein-induced ototoxicity in rats.
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Inflammation Mediators; Lutein; Male; Ototoxicity; Oxidative Stress; Rats, Wistar; Vestibulocochlear Nerve; Vestibulocochlear Nerve Diseases | 2021 |
Exposure to lutein-loaded nanoparticles attenuates Parkinson's model-induced damage in Drosophila melanogaster: Restoration of dopaminergic and cholinergic system and oxidative stress indicators.
Topics: Acetylcholinesterase; Animals; Cholinergic Neurons; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drosophila melanogaster; Lutein; Nanoparticles; Neurodegenerative Diseases; Neurotoxicity Syndromes; Oxidative Stress; Parkinson Disease | 2021 |
Histopathological and Biochemical Assessment of Neuroprotective Effects of Sodium Valproate and Lutein on the Pilocarpine Albino Rat Model of Epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Humans; Lutein; Neuroprotective Agents; Pilocarpine; Rats; Valproic Acid | 2021 |
Lutein exerts its cardioprotective effect against the experimental model of isoprenaline-induced myocardial infarction via MIAT/miR-200a/Nrf2/TXINP pathway.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Isoproterenol; Lutein; MicroRNAs; Myocardial Infarction; NF-E2-Related Factor 2; Rats; RNA, Long Noncoding; Signal Transduction | 2021 |
Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model.
Topics: Animals; Blotting, Western; Diet, High-Fat; Disease Models, Animal; Lipid Metabolism; Lutein; Male; Obesity; Oxidative Stress; Rats; Rats, Wistar; Retina; Zeaxanthins | 2017 |
Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice.
Topics: Administration, Oral; Animals; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Gene Expression Regulation; Laser Coagulation; Lutein; Mice; NADPH Oxidase 4; Reactive Oxygen Species | 2018 |
Lutein and Zeaxanthin Isomers Protect against Light-Induced Retinopathy via Decreasing Oxidative and Endoplasmic Reticulum Stress in BALB/cJ Mice.
Topics: Activating Transcription Factor 4; Activating Transcription Factor 6; Animals; Antioxidants; Apoptosis; Disease Models, Animal; eIF-2 Kinase; Electroretinography; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Isomerism; JNK Mitogen-Activated Protein Kinases; Light; Lutein; Male; Mice, Inbred BALB C; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; Photoreceptor Cells, Vertebrate; Retinal Diseases; Signal Transduction; Zeaxanthins | 2018 |
Lutein Suppresses Oxidative Stress and Inflammation by Nrf2 Activation in an Osteoporosis Rat Model.
Topics: Animals; Antioxidants; Disease Models, Animal; Female; Inflammation; Lipid Peroxidation; Lutein; NF-E2-Related Factor 2; Osteoclasts; Osteoporosis; Ovariectomy; Oxidative Stress; RANK Ligand; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factors | 2018 |
Lutein and Zeaxanthin Isomers Reduce Photoreceptor Degeneration in the
Topics: Animals; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Eye Proteins; Female; Lutein; Male; Mice; Photoreceptor Cells, Vertebrate; Retinitis Pigmentosa; Stereoisomerism; Zeaxanthins | 2018 |
Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina.
Topics: Animals; Cattle; Coloring Agents; Disease Models, Animal; Electroretinography; Lutein; Perfusion; Retinal Diseases; Retinal Ganglion Cells | 2019 |
Hydroalcoholic extract of Tagetes erecta L. flowers, rich in the carotenoid lutein, attenuates inflammatory cytokine secretion and improves the oxidative stress in an animal model of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Ethanol; Flowers; Inflammation; Lutein; Male; Mice; Mucins; Oxidative Stress; Plant Extracts; Tagetes; Water | 2019 |
Calorie restriction (CR) and CR mimetics for the prevention and treatment of age-related eye disorders.
Topics: Administration, Oral; Animals; Antioxidants; Caloric Restriction; Disease Models, Animal; Eicosapentaenoic Acid; Eye Diseases; Forecasting; Humans; Lactoferrin; Lutein; Mice; Mice, Knockout; Polyphenols; Rats | 2013 |
Carotenoid lutein protects the kidney against cisplatin-induced acute renal failure.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Antioxidants; Bone Marrow Cells; Carotenoids; Catalase; Cisplatin; Disease Models, Animal; Female; Glutathione; Injections; Kidney; Lipid Peroxidation; Lutein; Malondialdehyde; Mice; Superoxide Dismutase | 2013 |
Oxidative stress in rats with hyperhomo-cysteinemia and intervention effect of lutein.
Topics: Animals; Antioxidants; Atherosclerosis; Disease Models, Animal; Down-Regulation; Endothelium, Vascular; Hyperhomocysteinemia; Intercellular Adhesion Molecule-1; Lutein; Male; Oxidative Stress; Rats, Wistar; Transcription Factor RelA | 2014 |
Lutein protects against ischemia/reperfusion injury in rat kidneys.
Topics: Animals; Antioxidants; Biomarkers; Disease Models, Animal; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Lutein; Male; Oxidants; Oxidation-Reduction; Oxidative Stress; Rats; Reperfusion Injury | 2015 |
Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.
Topics: Animals; Carrier Proteins; Choroid; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorescein Angiography; Intravitreal Injections; Lutein; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Minerals; NLR Family, Pyrin Domain-Containing 3 Protein; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Vitamins | 2015 |
Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Topics: Abdominal Fat; Adiposity; Animals; Biomarkers; Blood Glucose; Cholesterol; Cytoprotection; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Insulin; Insulin Resistance; Liver; Lutein; Male; Non-alcoholic Fatty Liver Disease; Protective Agents; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Triglycerides | 2015 |
Lutein protects against ischemia/reperfusion injury in rat skeletal muscle by modulating oxidative stress and inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lipid Peroxidation; Lutein; Male; Muscle, Skeletal; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2015 |
Elevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids.
Topics: Aging; Animals; Cross-Sectional Studies; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Fluorescein Angiography; Fovea Centralis; Fundus Oculi; Lutein; Macaca mulatta; Retinal Diseases; Zeaxanthins | 2016 |
Genetic dissection in a mouse model reveals interactions between carotenoids and lipid metabolism.
Topics: Animals; beta Carotene; Carotenoids; Cholesterol; Diet; Disease Models, Animal; Energy Metabolism; Humans; Lipid Metabolism; Lipids; Lipolysis; Liver; Lutein; Metabolism; Mice; Transcriptome; Triglycerides; Zeaxanthins | 2016 |
Effect of a complex lutein formula in an animal model for light-induced retinal degeneration.
Topics: Animals; Anthocyanins; Calendula; Cassia; Disease Models, Animal; Drug Evaluation, Preclinical; Electroretinography; Light; Lutein; Lycium; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Retina; Retinal Diseases; Rhodiola; Vaccinium myrtillus | 2016 |
Compared with Powdered Lutein, a Lutein Nanoemulsion Increases Plasma and Liver Lutein, Protects against Hepatic Steatosis, and Affects Lipoprotein Metabolism in Guinea Pigs.
Topics: Adipose Tissue; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Emulsions; Fatty Liver; Guinea Pigs; Liver; Lutein; Male; Oxidative Stress; Powders; Protective Agents; Triglycerides | 2016 |
Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Immunohistochemistry; Lutein; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neuroglia; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity | 2017 |
[Light-absorbing and antiradical properties of a product with lutein and zeaxanthin in vitro and kinetics of carotinoids at single oral administration on rats].
Topics: Administration, Oral; Animals; Antioxidants; Chromatography, High Pressure Liquid; Disease Models, Animal; Eye Diseases; Free Radicals; Lutein; Oxidation-Reduction; Rats; Rats, Wistar; Spectrophotometry; Xanthophylls; Zeaxanthins | 2008 |
Lutein prevents cataract development and progression in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar | 2009 |
Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion.
Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Calbindin 2; Disease Models, Animal; In Situ Nick-End Labeling; Lutein; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; S100 Calcium Binding Protein G; Tyrosine | 2009 |
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation.
Topics: Animals; Antioxidants; Disease Models, Animal; Electroretinography; Escherichia coli; Glial Fibrillary Acidic Protein; Immunoenzyme Techniques; In Situ Nick-End Labeling; Lipopolysaccharides; Lutein; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroglia; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Retinitis; Reverse Transcriptase Polymerase Chain Reaction; Rhodopsin; STAT3 Transcription Factor; Uveitis, Posterior | 2009 |
Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex.
Topics: Aldehydes; Animals; Antigens, Nuclear; Antioxidants; Biomarkers; Brain Diseases, Metabolic; Cerebral Cortex; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Docosahexaenoic Acids; Drug Therapy, Combination; Fluorescent Antibody Technique; Glucose; Glutathione; Glutathione Peroxidase; Hyperglycemia; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Treatment Outcome | 2010 |
Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage.
Topics: Acetaminophen; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Bilirubin; Biomarkers; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Glutathione Peroxidase; Hydroxyproline; Lipid Peroxidation; Liver; Lutein; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2010 |
Retinol-deficient rats can convert a pharmacological dose of astaxanthin to retinol: antioxidant potential of astaxanthin, lutein, and β-carotene.
Topics: Animals; Antioxidants; beta Carotene; Biotransformation; Chromatography, High Pressure Liquid; Disease Models, Animal; Fatty Acids; Lipid Peroxidation; Liver; Lutein; Male; Microsomes, Liver; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Vitamin A Deficiency; Xanthophylls | 2010 |
Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Fovea Centralis; Light; Lutein; Macaca mulatta; Macular Degeneration; Oxidative Stress; Radiation-Protective Agents; Xanthophylls; Zeaxanthins | 2011 |
Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke.
Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Lutein; Male; Mice; Neurons; Neuroprotective Agents; Oxidative Stress; Stroke | 2012 |
Carotenoid lutein protects rats from gastric ulcer induced by ethanol.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; Enzymes; Ethanol; Female; Gastric Mucosa; Glutathione; Lutein; Oxidative Stress; Rats; Rats, Wistar; Severity of Illness Index; Stomach Ulcer; Time Factors | 2012 |
Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Cobalt; Cyclooxygenase 2; Disease Models, Animal; Electroretinography; Glial Fibrillary Acidic Protein; Hypoxia; Interleukin-1beta; Lutein; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroglia; NF-kappa B; Photic Stimulation; Rats; Reperfusion Injury; Retina; Retinal Diseases; Tumor Necrosis Factor-alpha | 2012 |
Neuroprotective effects of lutein in a rat model of retinal detachment.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Cell Count; Cell Survival; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Injections, Intraperitoneal; Lutein; Male; Neuroprotective Agents; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Retinal Detachment; Rhodopsin | 2013 |
Protective effects of various antioxidants during ischemia-reperfusion in the rat retina.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Disease Models, Animal; Glutathione; Lutein; Male; Malondialdehyde; Oxidative Stress; Phytotherapy; Plant Preparations; Rats; Rats, Long-Evans; Reperfusion Injury; Retina; Retinal Diseases; Retinal Vessels; Teucrium; Trigonella; Vitamin E | 2006 |
Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Blotting, Western; Cell Line; Ciliary Body; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; I-kappa B Proteins; Iris; Lipopolysaccharides; Lutein; Macrophages; Male; Mice; Microscopy, Confocal; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Inbred Lew; Salmonella typhimurium; Uveitis, Anterior | 2006 |
Egg yolk improves lipid profile, lipid peroxidation and retinal abnormalities in a murine model of genetic hypercholesterolemia.
Topics: Animals; Apolipoproteins E; Disease Models, Animal; Egg Yolk; Hypercholesterolemia; Lipid Peroxidation; Lipids; Lutein; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Retina; Thiobarbituric Acid Reactive Substances; Tight Junctions; Vacuoles | 2008 |
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Choroid; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Laser Coagulation; Lutein; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-KappaB Inhibitor alpha; Reproducibility of Results; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2007 |
Cancer prevention by natural carotenoids.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; beta Carotene; Carotenoids; Colonic Neoplasms; Cryptoxanthins; Disease Models, Animal; Fruit; Humans; Lutein; Lycopene; Methylnitrosourea; Mice; Rats; Rats, Inbred F344; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vegetables; Xanthophylls; Zeaxanthins | 2000 |
Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study.
Topics: Adult; Animals; Apolipoproteins E; Arteriosclerosis; beta Carotene; Carotid Arteries; Cell Movement; Cells, Cultured; Coculture Techniques; Cohort Studies; Culture Media, Conditioned; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Los Angeles; Lutein; Male; Mice; Mice, Knockout; Middle Aged; Monocytes; Muscle, Smooth, Vascular; Oxidation-Reduction; Risk Factors; Ultrasonography | 2001 |